EFFECT OF WITHANIA SOMNIFERA (ASHWAGANDHA) ON LIVER FUNCTION PARAMETERS IN MDD (MAJOR DEPRESSIVE DISORDER) PATIENTS TAKING SERTRALINE.
Main Article Content
Keywords
Antidepressants, Ashwagandha, Liver function test, MDD (Major depressive Disorder), Sertraline
Abstract
Aim and Objectives: Aim: To study the effect of administration of sertraline alone and sertraline with ashwagandha on liver function parameters in patients with MDD (Major Depressive Disorder).. Objectives:1.To estimate the effect of sertraline on Liver Function parameters in patients with MDD. 2.To estimate the effect of co-administration of ashwagandha with sertraline on liver function parameters. 3. To compare liver function parameters of both the groups before and after treatment. Material and Methods: This was an open labelled, randomized, comparative, prospective study involving 80 newly diagnosed patients with MDD (Major depressive Disorder) according to inclusion and exclusion criteria. After enrolling, patients were randomly allocated in either of the groups. One who are taking routine treatment with sertraline (Sertraline Group) and another who are given ashwagandha 250mg twice a day with their routine treatment with sertraline (Sertraline + Ashwagandha Group). All liver function parameters were investigated before starting the treatment and reinvestigated after a period of 3 months of drug treatment in both the groups. Results: In sertraline group, values of SGOT, SGPT, Total Protein and Globulin levels were significantly increased. Whereas there was no significant difference in values of other parameters. In sertraline + ashwagandha group, there was no significant difference in values of any liver function parameters before and after three months of treatment. Conclusion: We can conclude prolonged treatment with sertraline can increase few liver function parameters i.e., SGOT, SGPT, Total proteins and Globulin which can be prevented by using ashwagandha with the sertraline. However, sertraline + ashwagandha does not have any effect on any liver parameters.
References
2. Abraham RA. To Study If Teachers Are Affected by Depression In Schools On The Basis Of Their Gender, Marital Status And Family Structure. IJFANS International Journal of Food and Nutritional Sciences. Journal Volume 11, Iss 8, Dec 2022; 1914-1920
3. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR* D study: treating depression in the real world. Cleveland Clinic journal of medicine. 2008 Jan 1;75(1):57-66. DOI: 10.3949/ccjm.75.1.57 PMID: 18236731
4. Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, Van Rhoads RS. American Psychiatric Association practice guidelines for the treatment of patients with major depressive disorder. Am J Psychiatry. 2010;167(Suppl 10):9-118.
5. DeLucia V, Kelsberg G, Safranek S. Which SSRIs most effectively treat depression in adolescents? J Fam Pract. 2016 Sep;65(9):632-634. URI: https://hdl.handle.net/10355/56517
6. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Progress in neuro-psychopharmacology and biological psychiatry. 2003 Feb 1;27(1):85-102. Doi: https://doi.org/10.1016/S0278-5846(02)00338-X
7. Murdoch D, McTavish D. Sertraline: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs. 1992 Oct;44:604-624. DOI: https://doi.org/10.2165/00003495-199244040-00007
8. Ebuehi OA, Ikanone CE, Balogun AA, Akinwande AI, Famuyiwa OO. Effects of administration of sertraline, clozapine, amitriptyline and imipramine on brain serotonin, liver enzymes and blood chemistry of rabbit. International Journal of Biological and Chemical Sciences. 2009;3(1); 85-94. DOI: 10.4314/ijbcs.v3i1.42739
9. Suen CF, Boyapati R, Simpson I, Dev A. Acute liver injury secondary to sertraline. Case Reports. 2013 Sep 26;2013:bcr2013201022; 1-5, doi: http://dx.doi.org/10.1136/bcr-2013-201022
10. Pala B. Withania Somnifera (Ashwagandha): A Source Of Therapeutic Agents Nikhil Teli, Trupti Bagwe 2, Ashwathi Kandampully And Bhavini Pala. Review Article. 2014 Int.J.Curr.Res.Chem.Pharma.Sci. Volume 1 Issue: 7 2014: 36-43
11. Maity T, Adhikari A, Bhattacharya K, Biswas S, Debnath PK, Maharana CS. A study on evalution of antidepressant effect of imipramine adjunct with Aswagandha and Bramhi. Nepal Med Coll J. 2011 Dec 1;13(4):250-253.
12. Umadevi M, Rajeswari R, Rahale CS, Selvavenkadesh S, Pushpa R, Kumar KS, Bhowmik D. Traditional and medicinal uses of Withania somnifera. The pharma innovation. 2012 Nov 1;1(9, Part A):102.
13. Sultana N, Shimmi SC, Parash MT, Akhtar J. Effects of ashwagandha (Withania somnifera) root extract on some serum liver marker enzymes (AST, ALT) in gentamicin intoxicated rats. Journal of Bangladesh Society of Physiologist. 2012 Jul 10;7(1):1-7, DOI: https://doi.org/10.3329/jbsp.v7i1.11152
14. Khalil HM, Eliwa HA, El-Shiekh RA, Al-Mokaddem AK, Hassan M, Tawfek AM, El-Maadawy WH. Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits in thioacetamide-induced rat model of hepatic encephalopathy via induction of Nrf2/HO-1 and mitigation of NF-κB/MAPK signaling pathways. Journal of Ethnopharmacology. 2021 Sep 15;277:114-141. doi: https://doi.org/10.1016/j.jep.2021.114141
15. Udayakumar R, Kasthurirengan S, Mariashibu TS, Rajesh M, Anbazhagan VR, Kim SC, Ganapathi A, Choi CW. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. International journal of molecular sciences. 2009 May 20;10(5):2367-2382, doi: https://doi.org/10.3390/ijms10052367
16. García-Pando AC, del Pozo JG, Sánchez AS, Martin AV, de Castro AR, Lucena MI. Hepatotoxicity associated with the new antidepressants. Journal of Clinical Psychiatry. 2002 Feb 1;63(2):135-137.
17. Tabak F, Gunduz F, Tahan V, Tabak O, Ozaras R. Sertraline hepatotoxicity: report of a case and review of the literature. Digestive diseases and sciences. 2009 Jul;54:1589-1591. DOI: https://doi.org/10.1007/s10620-008-0524-3
18. Sabina EP, Rasool M, Vedi M, Navaneethan D, Ravichander M, Parthasarthy PO, Thella SR. Hepatoprotective and antioxidant potential of Withania somnifera against paracetamol-induced liver damage in rats. Int J Pharm Pharm Sci. 2013;5(2):648-651.
19. Nabi SU, Wani AR, Dey S. Therapeutic effect of ashwagandha (Withaniasomnifera L.) in liver dysfunction of old dogs. Appl Biol Res. 2014; Vol.16; issue.2: 232-236. Doi ; http://dx.doi.org/10.5958/0974-4517.2014.00015.9
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Vaghasiya Keyurkumar Mansukhbhai
3rd year PG Student, Department of Pharmacology, KIMS, Karad.
Dr. Sujata Jadhav
Professor, Department of Pharmacology, KIMS, Karad, India
Dr. Ajish Mangot
Associate professor, Department of Psychiatry, KIMS, Karad.
Dr. Chitra Khanwelkar
Professor, Department of Pharmacology, KIMS, Karad, India.
Dr. Aditya Shah
2nd year PG Student, Department of Pharmacology, KIMS, Karad, India.